FENC - CIK 0001211583
FENNEC PHARMACEUTICALS INC. (FENC) reported revenue of $44.64M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $44.64M | -6.1% |
| FY 2024 | $47.54M | +123.7% |
| FY 2023 | $21.25M | +1284.5% |
| FY 2022 | $1.53M | +667.5% |
| FY 2020 | $200.00K | - |
| FY 2019 | $0.00 | - |
| FY 2018 | $0.00 | - |
| FY 2017 | $0.00 | - |
| FY 2016 | $0.00 |
FENNEC PHARMACEUTICALS INC. (FENC) reported revenue of $44.64M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, FENNEC PHARMACEUTICALS INC.'s revenue grew from $0.00 to $44.64M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| FY 2015 | $0.00 | - |
| FY 2014 | $0.00 | - |
| FY 2013 | $0.00 | - |
| FY 2012 | $0.00 | - |
| FY 2011 | $0.00 | - |